agilon health closed at $113.77 on Nov 5, up 18.23%, 43.4% below its 52-week closing high. Volume of 585.6K shares was 3.03× its 20-day average (well above normal).
Split-adjusted performance: +32.8% over one month, +87.6% over six months, +528.4% over one year.
In the quarter ended Sep 30, 2026, revenue was $1.52B, up 5.9% from a year earlier, with a net margin of 2.3%.
Short interest was 899.1K shares at the Oct 15 settlement, down 10.9% from the prior report (7.3% of float, 4.6 days to cover).